13 Panel CSI CLIA Screen In-Vitro Drug Test Cup, CLIA Waived, OTC with 3 Adulterants, 25/Box
Brand : CSI™ Drug Test Cups
$110.50
- SKU:
- CSI-CUP-2135A3
- Per Each:
- 25
CSI Cup CLIA Waived Drug Screening Test Cup 13 Panel with Validity Tests (SVT)
This high quality CLIA Waived drug test cup is an easy, fast, qualitative, competitive binding immunoassay method for screening without the need of instrumentation. 
The CSI Test Cup is a No Step, fully integrated self contained multi-drug screening cup. No tipping or turning required. Read results in 5 minutes. The cup is FDA Cleared and CLIA Waived. This non-branded cup is a fast visual, competitive panel immunoassay that can be used for the simultaneous, qualitative detection of multiple drug metabolites at specific cutoff levels in human urine.
Features & Benefits
- CLIA Waived
- OTC - Over-The-Counter FDA Approved
- At Home Use Approved
- FDA 510(K) Approved
- Health Canada Approved
- CE Marking - Meets all European Conformity Standards
- Sold in boxes of 25 tests
- New "Click Seal" cap!
- No step cup
- Up to 99% Accurate
- Dual scale Temperature Strip verifies if urine is "fresh" and not diluted
- Adheres to the SAMHSA Cutoff Levels
- Immediate Results
- Shelf-life up to 24 months
- New easy to open top for the confirmation lab
Download & Print Reference Materials
Multi-Panel CLIA Waived Drug Test Package Insert
Multi-Panel CLIA Waived Drug Test Instruction Sheet
| Thirteen Panel Configuration | ||
| Item Number | Drugs Tested | Adulterants Tested |
| CSI-CUP-2135A3 | AMP, BAR, BUP, BZO, COC, MET, MDMA, MTD, OPI-300, OXY, PCP, TCA, THC | OX, SG, PH |
| SAMSHA Approved CLIA Waived Drug Panel Options | |||||
| Drug Name | Abbreviation | Cutoff Level | Minimum Detection Time in Urine* | Maximum Detection Time in Urine* | Calibrator |
| Amphetamine | AMP | 1000 ng/ml | 2-7 hours | 2-4 days | D-Amphetamine |
| Barbiturates | BAR | 300 ng/ml | 2-4 hours | 1-3 weeks | Secobarbital |
| Benzodiazepines | BZO / BZD | 300 ng/ml | 2-7 hours | 1-4 days | Benzoylecgonine |
| Buprenorphine | BUP | 10 ng/ml | 2-3 hours | 1 day | Buprenorphine |
| Cocaine | COC | 300 ng/ml | 1-4 hours | 2-4 days | Benzoylecgonine |
| Ecstasy | MDMA | 500 ng/ml | 1-3 days | 1-2 days | D,L- Methylenedioxy-methamphetamine |
| Marijuana | THC | 50 ng/ml | 2 hours | up to 40 days | 11-nor-Δ9-THC-9 COOH |
| Methadone | MTD / MAD | 300 ng/ml | 3-8 hours | 1-3 days | Methadone |
| Methamphetamine | mAMP / MET | 1000 ng/ml | 2-7 hours | 2-4 days | D-Methamphetamine |
| Morphine | MOP / OPI-300 | 300 ng/ml | 2 hours | 2-3 days | Morphine |
| Opiates | OPI | 2000 ng/ml | 2 hours | 2-3 days | Morphine |
| Oxycodone | OXY | 100 ng/ml | 1-3 hours | 1-2 days | Oxycodone |
| Phencyclidine | PCP | 25 ng/ml | 4-6 hours | 7-14 days | Phencyclidine |
| Propoxyphene | PPX | 300 ng/ml | 1-2 days | N/A | Propoxyphene |
| Tricyclic Antidepressants | TCA | 1000 ng/ml | 8-12 hours | 2-7 days | Nortriptyline |
| * Detection times are not guaranteed. Reference configuration above for included drug panels. This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas Chromatography/Mass Spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated. | |||||
| Optional CLIA Waived Drug Panels (call 404-840-8900 for more information) | |||||
| Drug Name | Abbreviation | Cutoff Level | Minimum Detection Time in Urine* | Maximum Detection Time in Urine* | Calibrator |
| Amphetamine | AMP | 500 ng/ml | 2-7 hours | 2-4 days | D-Amphetamine |
| Cocaine | COC | 150 ng/ml | 1-4 hours | 2-4 days | Benzoylecgonine |
| EDDP | EDDP | 300 ng/ml | 1-4 hours | 2-4 days | 2-Ethylidene-1,5-dimethyl-3,3-dipheylpyrrolidine |
| Methamphetamine | mAMP / MET | 500 ng/ml | 2-7 hours | 2-4 days | D-Methamphetamine |
| * Detection times are not guaranteed. Reference configuration above for included drug panels. This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas Chromatography/Mass Spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated. | |||||
TransMed Company offers the following optional Forensic Use Only (FUO) Panels: K2, K3, EtG, Tramadol and Fenytanyl.
